Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task

Psychopharmacology

Volumn 225, Issue 3, 2013, Pages 719-731

  Baarendse, Petra J J ^a   Winstanley, Catharine A ^c   Vanderschuren, Louk J M J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Decision making; Dopamine; Impulsivity; Noradrenaline; Rat gambling task; Serotonin

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CITALOPRAM; DOPAMINE; NORADRENALIN; SEROTONIN; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DOPAMINE UPTAKE; HABITUATION; IMPULSIVENESS; MALE; MENTAL DISSOCIATION; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; NORADRENALIN UPTAKE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PROBABILITY; PUNISHMENT; RAT; REINFORCEMENT; REWARD; SEROTONINERGIC TRANSMISSION; STIMULUS RESPONSE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; DECISION MAKING; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMBLING; IMPULSIVE BEHAVIOR; MALE; NOREPINEPHRINE; RATS; RATS, INBRED STRAINS;

EID: 84873639399     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2857-z     Document Type: Article

References (93)

1. Arnsten AFT (1997) Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11:151-162
2. Arnsten AFT (2000) Through the looking glass: differential noradrenergic modulation of prefrontal cortical function. Neural Plast 7:133-146
3. Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28:403-450
4. Baarendse PJJ, Vanderschuren LJMJ (2012) Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology 219:313-326
5. Bark R, Dieckmann S, Bogerts B, Northoff G (2005) Deficit in decision making in catatonic schizophrenia: an exploratory study. Psychiatry Res 134:131-141
6. Bechara A, Damasio H (2002) Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 40:1675-1689
7. Bechara A, Damasio AR, Damasio H, Anderson SW (1994) Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50:7-15
8. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001) Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39:376-389
9. Berridge KC (2007) The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 191:391-431
10. Blondeau C, Dellu-Hagedorn F (2007) Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61:1340-1350
11. Boureau Y-L, Dayan P (2010) Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology 36:74-97
12. Bouret S, Sara SJ (2005) Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci 28:574-582
13. Brand M, Labudda K, Kalbe E, Hilker R, Emmans D, Fuchs G, Kessler J, Markowitsch HJ (2004) Decision-making impairments in patients with Parkinson's disease. Behav Neurol 15:77-85
14. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ (2005) Decision-making impairments in patients with pathological gambling. Psychiatry Res 133:91-99
15. Brand M, Recknor EC, Grabenhorst F, Bechara A (2007) Decisions under ambiguity and decisions under risk: correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules. J Clin Exp Neuropsychol 29:86-99
16. Cardinal RN, Robbins TW, Everitt BJ (2000) The effects of d-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology 152:362-375
17. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380
18. Cavedini P, Riboldi G, Keller R, D'annucci A, Bellodi L (2002) Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry 51:334-341
19. Cole BJ, Robbins TW (1987) Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology 91:458-466
20. Cole BJ, Robbins TW (1992) Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology 7:129-142
21. Cools R, Roberts AC, Robbins TW (2008) Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12:31-40
22. Cools R, Nakamura K, Daw ND (2011) Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacology 36:98-113
23. Dalley JW, McGaughy J, O'Connell MT, Cardinal RN, Levita L, Robbins TW (2001) Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 21:4908-4914
24. Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28:771-784
25. Dalley JW, Everitt BJ, Robbins TW (2011) Impulsivity, compulsivity, and top-down cognitive control. Neuron 69:680-694
26. Dayan P, Huys QJ (2008) Serotonin, inhibition, and negative mood. PLoS Comput Biol 4:e4
27. Denk F, Walton ME, Jennings KA, Sharp T, Rushworth MFS, Bannerman DM (2005) Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology 179:587-596
28. Eagle DM, Baunez C (2010) Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 34:50-72
29. Ernst M, Paulus MP (2005) Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry 58:597-604
30. Ernst M, Grant SJ, London ED, Contoreggi CS, Kimes AS, Spurgeon L (2003) Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry 160:33-40
31. Evenden JL (1999) Varieties of impulsivity. Psychopharmacology 146:348-361
32. Fernando AB, Economidou D, Theobald DE, Zou MF, Newman AH, Spoelder M, Caprioli D, Moreno M, Hipólito L, Aspinall AT, Robbins TW, Dalley JW (2012) Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology 219:341-352
33. Floresco SB, Jentsch JD (2011) Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 36:227-250
34. Floresco SB, Magyar O (2006) Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology 188:567-585
35. Floresco SB, Tse MT, Ghods-Sharifi S (2008a) Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33:1966-1979
36. Floresco SB, St. Onge JR, Ghods-Sharifi S, Winstanley CA (2008b) Cortico-limbic-striatal circuits subserving different forms of cost-benefit decision making. Cogn Affect Behav Neurosci 8:375-389
37. Franken IH, Muris P (2005) Individual differences in decision making. Personal Individ Differ 39:991-998
38. Franken IH, van Strien JW, Nijs I, Muris P (2008) Impulsivity is associated with behavioral decision-making deficits. Psychiatry Res 158:155-163
39. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22:1757-1763
40. Garon N, Moore C, Waschbusch DA (2006) Decision making in children with ADHD only, ADHD- anxious/depressed, and control children using a child version of the Iowa gambling task. J Atten Disord 9:607-619
41. Grant JE, Potenza MN (2007) Treatments for pathological gambling and other impulse control disorders. In: Nathan P, Gorman J (eds) A guide to treatments that work. Oxford University Press, Oxford, pp 561-579
42. Hanson KL, Luciana M, Sullwold K (2008) Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend 96:99-110
43. Hollander E, Rosen J (2000) Impulsivity. J Psychopharmacol 14:S39-S44
44. Johnson SA, Yechiam E, Murphy RR, Queller S, Stout JC (2006) Motivational processes and autonomic responsivity in Asperger's disorder: evidence from the Iowa Gambling Task. J Int Neuropsychol Soc 12:668-676
45. Jollant F, Bellivier F, Leboyer M, Astruc B, Torres S, Verdier R, Castelnau D, Malafosse A, Courtet P (2005) Impaired decision making in suicide attempters. Am J Psychiatry 162:304-310
46. Kranz GS, Kasper S, Lanzenberger R (2010) Reward and the serotonergic system. Neuroscience 166:1023-1035
47. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8:1450-1457
48. Lawrence NS, Wooderson S, Mataix-Cols D, David R, Speckens A, Phillips ML (2006) Decision making and set shifting impairments are associated with distinct symptom dimensions in obsessive-compulsive disorder. Neuropsychology 20:409-419
49. Luman M, Oosterlaan J, Knol DL, Sergeant JA (2008) Decision-making in ADHD: sensitive to frequency but blind to the magnitude of penalty? J Child Psychol Psychiatry 49:712-722
50. Malloy-Diniz L, Fuentes D, Leite WB, Correa H, Bechara A (2007) Impulsive behavior in adults with attention deficit/hyperactivity disorder: characterization of attentional, motor and cognitive impulsiveness. J Int Neuropsychol Soc 13:693-698
51. Mavaddat N, Kirkpatrick PJ, Rogers RD, Sahakian BJ (2000) Deficits in decision-making in patients with aneurysms of the anterior communicating artery. Brain 123:2109-2117
52. McDonald J (2009) Handbook of biological statistics, 2nd edn. Sparky House Publishing, Baltimore
53. Mitchell MR, Vokes CM, Blankenship AL, Simon NW, Setlow B (2011) Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats. Psychopharmacology 218:703-712
54. Morgan MJ, Impallomeni LC, Pirona A, Rogers RD (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naïve controls. Neuropsychopharmacology 31:1562-1573
55. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32:34-41
56. O'Carroll RE, Papps BP (2003) Decision making in humans: the effect of manipulating the central noradrenergic system. J Neurol Neurosurg Psychiatry 74:376-378
57. O'Donnell JM, Marek GJ, Seiden LS (2005) Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. Neurosci Biobehav Rev 29:785-798
58. Ouyang M, Young MB, Lestini MM, Schutsky K, Thomas SA (2012) Redundant catecholamine signaling consolidates fear memory via phospholipase C. J Neurosci 32:1932-1941
59. Paine TA, Tomasiewicz HC, Zhang K, Carlezon WA (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62:687-693
60. Paterson NE, Ricciardi J, Wetzler C, Hanania T (2011) Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and D-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neurosci Res 69:41-50
61. Pattij T, Vanderschuren LJ (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-199
62. Raylu N, Oei TP (2002) Pathological gambling. A comprehensive review. Clin Psychol Rev 22:1009-1061
63. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163:362-380
64. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287
65. Robbins TW, Everitt BJ (2007) A role for mesencephalic dopamine in activation: commentary on Berridge (2006). Psychopharmacology 191:433-437
66. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037
67. Rogers RD (2011) The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology 36:114-132
68. Rogers RD, Robbins TW (2001) Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 11:250-257
69. Salamone JD, Cousins MS, Bucher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 65:221-229
70. Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461-482
71. Schutter DJ, van Bokhoven I, Vanderschuren LJ, Lochman JE, Matthys W (2011) Risky decision making in substance dependent adolescents with a disruptive behavior disorder. J Abnorm Child Psychol 39:333-339
72. Seedat S, Kesler S, Niehaus DJ, Stein DJ (2000) Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 11:185-186
73. Sevy S, Hassoun Y, Bechara A, Yechiam E, Napolitano B, Burdick K, Delman H, Malhotra A (2006) Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels. Psychopharmacology 188:228-235
74. Shurman B, Horan WP, Nuechterlein KH (2005) Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr Res 72:215-224
75. Simon NW, Gilbert RJ, Mayse JD, Bizon JL, Setlow B (2009) Balancing risk and reward: a rat model of risky decision making. Neuropsychopharmacology 34:2208-2217
76. Simon NW, Montgomery KS, Beas BS, Mitchell MR, LaSarge CL, Mendez IA, Bañuelos C, Vokes CM, Taylor AB, Haberman RP, Bizon JL, Setlow B (2011) Dopaminergic modulation of risky decision-making. J Neurosci 31:17460-17470
77. Sirviö J, Jäkälä P, Mazurkiewicz M, Haapalinna A, Riekkinen P Jr, Riekkinen PJ (1993) Dose- and parameter-dependent effects of atipamezole, an alpha 2-antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol Biochem Behav 45:123-129
78. St Onge JR, Floresco SB (2009) Dopaminergic regulation of risk based decision-making. Neuropsychopharmacology 34:681-697
79. Sun H, Cocker PJ, Zeeb FD, Winstanley CA (2012) Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex. Psychopharmacology 219:285-301
80. Tops M, Russo S, Boksem MA, Tucker DM (2009) Serotonin: modulator of a drive to withdraw. Brain Cogn 71:427-436
81. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549-554
82. Van den Brink W (2012) Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev 5:3-31
83. Van der Plas EA, Crone EA, van den Wildenberg WP, Tranel D, Bechara A (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706-719
84. Van Gaalen MM, Brueggeman RJ, Bronius PFC, Schoffelmeer ANM, Vanderschuren LJMJ (2006a) Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology 187:73-85
85. Van Gaalen MM, van Koten R, Schoffelmeer ANM, Vanderschuren LJMJ (2006b) Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60:66-73
86. Verdejo-García A, Rivas-Pérez C, Vilar-López R, Pérez-García M (2007) Strategic self-regulation, decision-making and emotion processing in poly-substance abusers in their first year of abstinence. Drug Alcohol Depend 86:139-146
87. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969-973
88. Winstanley CA (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 164:1301-1321
89. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528-8535
90. Zeeb FD, Winstanley CA (2011) Lesions of the basolateral amygdala and orbitofrontal cortex differentially affect acquisition and performance of a rodent gambling task. J Neurosci 31:2197-2204
91. Zeeb FD, Robbins TW, Winstanley CA (2009) Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology 34:2329-2343
92. Zermatten AM, Van der Linden MP, d'Acremont MM, Jermann FM, Bechara AP (2005) Impulsivity and decision making. J Nerv Ment Dis 193:647-650
93. Zhang XL, Wang GB, Zhao LY, Sun LL, Wang J, Wu P, Lu L, Shi J (2012) Clonidine improved laboratory-measured decision-making performance in abstinent heroin addicts. PLoS One 7:e29084